Novo Nordisk is in the lead, but not alone. Obesity doctors say they are gearing up for demand, predicted to be high. Some ...

The company had blamed FDA "resource constraints" for the delay, while a rival drug for hereditary angioedema received an ...

The drugs, sutezolid and delpazolid, have demonstrated strong antimicrobial activity and a notably better safety profile ...

An Ozempic-like drug prescribed for diabetes has been found to reduce the frequency of debilitating migraine. Researchers say ...

he Madre Fire became California's largest blaze so far this year, ripping through grasslands after breaking out Wednesday in southeastern San Luis Obispo County.

Astellas has suffered another major setback with geographic atrophy (GA) treatment Izervay, this time in the US.

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for bronchiectasis in the US.

Your complete playbook to a longer, stronger life—featuring professional workout advice, celebrity training secrets, nutrition tips, and more.